Ads

 

Ads

 

Ads

 

Top Healthcare Companies in China List by Market Cap as of August 2026

Top Healthcare Companies in China List by Market Cap as of August 2026. Biggest and Top Healthcare Companies in China Companies by Market Cap. Largest Top Healthcare Companies in China List by Market Cap as of August 2026.
Metatag Title
Top Healthcare Companies in China,
Metatag Abstract
Top Healthcare Companies in China, Biggest Healthcare Companies in China, Largest Healthcare Companies in China.
  1. Hubei Jumpcan Pharmaceutical

    World Rank (Aug-2026)
    4,496
    Market Cap (Aug-2026)
    3.596 Billion USD
    World Rank (Jan-05-2024)
    3,312
    Market Cap (Jan-05-2024)
    4.298 Billion USD
    World Rank (Jul-30-2023)
    3,849
    Market Cap (Jul-30-2023)
    3.574 Billion USD
    World Rank (Dec-25-2022)
    3,642
    Market Cap (Dec-25-2022)
    3.517 Billion USD
    World Rank (Jan-07-2022)
    3,891
    Market Cap (Jan-07-2022)
    4.02 Billion USD
    Annual Revenue in USD
    1,110 Million USD
    Annual Net Income in USD
    250 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    HUBEI JUMPCAN PHARMACEUTICAL is a pharmaceutical industries company focusing on the R & D(Research and development), manufacturing and trading of Chinese traditional medicine, Western medicine, daily use chemical based on Chinese traditional medicine and Chinese medicine health products. The headquarters is in China.
  2. Lepu Medical Technology (Beijing)

    World Rank (Aug-2026)
    4,515
    Market Cap (Aug-2026)
    3.580 Billion USD
    World Rank (Jan-05-2024)
    3,411
    Market Cap (Jan-05-2024)
    4.138 Billion USD
    World Rank (Jul-30-2023)
    2,706
    Market Cap (Jul-30-2023)
    5.559 Billion USD
    World Rank (Dec-25-2022)
    2,399
    Market Cap (Dec-25-2022)
    5.831 Billion USD
    World Rank (Jan-07-2022)
    2,671
    Market Cap (Jan-07-2022)
    6.46 Billion USD
    Annual Revenue in USD
    1,487 Million USD
    Annual Operating Income in USD
    401 Million USD
    Annual Net Income in USD
    309 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Medical devices and Medical equipment manufacturing company with headquarters is in Beijing, China.
  3. Hualan Biological Engineering

    World Rank (Aug-2026)
    4,518
    Market Cap (Aug-2026)
    3.577 Billion USD
    World Rank (Jan-05-2024)
    2,715
    Market Cap (Jan-05-2024)
    5.501 Billion USD
    World Rank (Jul-30-2023)
    2,567
    Market Cap (Jul-30-2023)
    5.908 Billion USD
    World Rank (Dec-25-2022)
    2,562
    Market Cap (Dec-25-2022)
    5.408 Billion USD
    World Rank (Jan-07-2022)
    2,153
    Market Cap (Jan-07-2022)
    8.42 Billion USD
    Annual Revenue in USD
    633 Million USD
    Annual Operating Income in USD
    209 Million USD
    Annual Net Income in USD
    151 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biopharmaceutical company with headquarters is in China.
  4. Beijing Tiantan Biological Products

    World Rank (Aug-2026)
    4,522
    Market Cap (Aug-2026)
    3.575 Billion USD
    World Rank (Jan-05-2024)
    2,210
    Market Cap (Jan-05-2024)
    7.106 Billion USD
    World Rank (Jul-30-2023)
    2,571
    Market Cap (Jul-30-2023)
    5.897 Billion USD
    World Rank (Dec-25-2022)
    2,650
    Market Cap (Dec-25-2022)
    5.177 Billion USD
    World Rank (Jan-07-2022)
    2,758
    Market Cap (Jan-07-2022)
    6.21 Billion USD
    Annual Revenue in USD
    597 Million USD
    Annual Operating Income in USD
    187 Million USD
    Annual Net Income in USD
    123 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Beijing Tiantan Biological Products is a voluntary public health driven alliance of vaccine manufacturers from developing countries, firmly engaged in research, development, manufacturing and supply of high-quality vaccines that are accessible to protect people against known and emerging infectious diseases globally. The company annual revenue is 466.45 million USD and 3,415 employees as on 2019. The headquarters is in China.
  5. Betta Pharmaceuticals

    World Rank (Aug-2026)
    4,595
    Market Cap (Aug-2026)
    3.486 Billion USD
    World Rank (Jan-05-2024)
    4,431
    Market Cap (Jan-05-2024)
    2.948 Billion USD
    World Rank (Jul-30-2023)
    4,045
    Market Cap (Jul-30-2023)
    3.333 Billion USD
    World Rank (Dec-25-2022)
    4,195
    Market Cap (Dec-25-2022)
    2.891 Billion USD
    World Rank (Jan-07-2022)
    3,256
    Market Cap (Jan-07-2022)
    5.06 Billion USD
    Annual Revenue in USD
    352 Million USD
    Annual Net Income in USD
    60 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Betta Pharmaceuticals is a senior executive team for innovative drug discovery and commercialization company mainly forced on drug development for cancer, diabetes and other major diseases that seriously affect human health. It is having more than 30 innovative drug projects in Betta’s pipeline with 15 in clinical stages, including 4 in phase III clinical trials. The company annual revenue is 284.1 million USD and 1,466 employee as on 2020. The headquarters is in China.
  6. Apeloa Pharmaceutical

    World Rank (Aug-2026)
    4,611
    Market Cap (Aug-2026)
    3.470 Billion USD
    World Rank (Jan-05-2024)
    4,966
    Market Cap (Jan-05-2024)
    2.494 Billion USD
    World Rank (Jul-30-2023)
    4,464
    Market Cap (Jul-30-2023)
    2.905 Billion USD
    World Rank (Dec-25-2022)
    3,657
    Market Cap (Dec-25-2022)
    3.489 Billion USD
    World Rank (Jan-07-2022)
    2,851
    Market Cap (Jan-07-2022)
    5.94 Billion USD
    Annual Revenue in USD
    1,404 Million USD
    Annual Net Income in USD
    150 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Apeloa Pharmaceutical is a engaged in the research and development, production and sales of pharmaceutical products company. The products are mainly concentrated in cardio cerebrovascular, anti infection, anti tumor and other treatment areas. The headquarters is in China.
    Facts About Company
    Apeloa Pharmaceutical company annual revenue was 10.5 billion CNY and annual net income was 989 million CNY for year ending Dec-2022.
  7. Guangdong Zhongsheng Pharmaceutical

    World Rank (Aug-2026)
    4,731
    Market Cap (Aug-2026)
    3.317 Billion USD
    World Rank (Jan-05-2024)
    5,896
    Market Cap (Jan-05-2024)
    1.888 Billion USD
    World Rank (Jul-30-2023)
    5,827
    Market Cap (Jul-30-2023)
    1.956 Billion USD
    World Rank (Dec-25-2022)
    3,155
    Market Cap (Dec-25-2022)
    4.208 Billion USD
    World Rank (Jan-07-2022)
    7,590
    Market Cap (Jan-07-2022)
    1.45 Billion USD
    Headquarters Country
  8. Jilin Aodong Pharmaceutical Group

    World Rank (Aug-2026)
    4,908
    Market Cap (Aug-2026)
    3.135 Billion USD
    World Rank (Jan-05-2024)
    4,980
    Market Cap (Jan-05-2024)
    2.481 Billion USD
    World Rank (Jul-30-2023)
    4,572
    Market Cap (Jul-30-2023)
    2.817 Billion USD
    World Rank (Dec-25-2022)
    4,602
    Market Cap (Dec-25-2022)
    2.555 Billion USD
    World Rank (Jan-07-2022)
    4,534
    Market Cap (Jan-07-2022)
    3.28 Billion USD
    Annual Revenue in USD
    335 Million USD
    Annual Net Income in USD
    259 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  9. Hybio Pharmaceutical

    World Rank (Aug-2026)
    5,007
    Market Cap (Aug-2026)
    3.035 Billion USD
    World Rank (Jan-05-2024)
    6,433
    Market Cap (Jan-05-2024)
    1.633 Billion USD
    World Rank (Jul-30-2023)
    7,599
    Market Cap (Jul-30-2023)
    1.263 Billion USD
    World Rank (Dec-25-2022)
    4,065
    Market Cap (Dec-25-2022)
    3.016 Billion USD
    World Rank (Jan-07-2022)
    6,908
    Market Cap (Jan-07-2022)
    1.72 Billion USD
    Headquarters Country
  10. Autobio Diagnostics

    World Rank (Aug-2026)
    5,095
    Market Cap (Aug-2026)
    2.942 Billion USD
    World Rank (Jan-05-2024)
    3,160
    Market Cap (Jan-05-2024)
    4.578 Billion USD
    World Rank (Jul-30-2023)
    3,121
    Market Cap (Jul-30-2023)
    4.725 Billion USD
    World Rank (Dec-25-2022)
    2,746
    Market Cap (Dec-25-2022)
    4.945 Billion USD
    World Rank (Jan-07-2022)
    3,133
    Market Cap (Jan-07-2022)
    5.30 Billion USD
    Annual Revenue in USD
    548 Million USD
    Annual Net Income in USD
    142 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Autobio manufactures instruments to improve medical laboratories. Headquarters is in China.

Share

Ads